MD 15 License: Importing IVD vs. Standard Medical Devices

If you're planning to import diagnostic kits, blood testing reagents, or any other in-vitro diagnostic product into India, you're about to discover that the path to an MD 15 license looks very different from what a standard medical device importer faces. Many foreign manufacturers and Indian importers apply with the same documentation they'd use for a surgical instrument or an imaging device and end up with queries, delays, and in some cases, outright rejection because they didn't understand how differently CDSCO treats importing IVD kits in India compared to standard medical devices. This guide breaks down exactly where the two paths diverge, what the CDSCO medical device import license MD 15 process demands for IVDs specifically, and why getting the documentation right the first time matters enormously for your market entry timeline.

Who Can Apply for an MD 15 License?

The application for an MD 15 license is always filed through an Authorized Indian Agent. This includes any wholesaler or importer who wants to import IVDs for sale and distribution in India, any foreign IVD manufacturer who wants to supply IVDs in India through an authorized agent, an Indian authorized agent who has a valid wholesale license for the sale or distribution of IVDs, any research institution importing IVDs for clinical trials, and any hospital or healthcare provider importing specialized IVDs for their patients. Importantly, MD 15 licenses are exclusive to the importer who obtained them. Any other firm wishing to import the same medical device must obtain its separate license; one importer's license cannot be utilized by another firm in India.

The Form MD 14 Application: Where Goods and IVDs Begin to Diverge

Both standard medical devices and IVDs use Form MD 14 for MD 15, but what goes inside that application package is where the two categories fundamentally differ. For a standard non-IVD device, such as a surgical instrument or an orthopedic implant, the core documentation covers device description, manufacturing site details, ISO 13485 certificate, CE or FDA approval, Free Sale Certificate, and basic performance data. It is a structured but relatively defined list. For IVDs, CDSCO requires significantly deeper technical documentation because IVD products are used to make clinical decisions directly from test results. A wrongly calibrated reagent doesn't just malfunction; it can give a false positive or false negative that directly affects patient diagnosis and treatment.

What Makes IVD Documentation Fundamentally Different?

1. The Performance Evaluation Report (PER)

This is the document that most distinguishes IVD applications from standard device applications. The Performance Evaluation Report for IVD CDSCO is a structured technical dossier that establishes your product's sensitivity, specificity, reproducibility, and repeatability using actual test data. If the PER is submitted from a NABL-accredited laboratory, the firm needs to submit three lots' reports with a valid NABL certificate, along with scope reflecting the applied product details. This three-lot requirement is critical; it's not enough to submit data from a single production batch. CDSCO wants to see consistency across multiple manufactured lots, which is a much higher bar than what standard device importers face.

2. Stability Data Requirements for IVD Kits

Manufacturers must demonstrate that IVD kits remain safe and effective under India's specific climate conditions, known as Zone IVb (30°C and 75% relative humidity). Even if a product has already passed testing for cooler climates like Europe (Zone II), CDSCO requires specific data proving it can withstand India's higher heat and humidity. To comply, the stability testing package must include real-time testing over the full shelf life, accelerated testing to predict performance under stress, in-use or open-vial stability studies, shipping studies covering transport conditions, and lot-to-lot variability testing to ensure consistency.

3. CDSCO IVD Risk Classification and What It Changes for Class C

Under MDR 2017, IVDs are ranked Class A, B, C, or D by risk. Class C includes high-consequence tests like blood screening and infectious disease diagnostics. For new products with no predicate, you must first obtain a clinical performance evaluation permit under the applicable regulatory pathway before applying for the full import license, adding a substantial regulatory phase. For existing products with a predicate, if a similar IVD is already licensed in India, the pathway is more direct, although you must still provide the required Performance Evaluation Report and stability data.

The IVD Import License Pathway: Step by Step

Step 1: Determine Device Classification

Confirm your IVD's classification under MDR 2017 — Class A, B, C, or D — since this determines which regulatory pathway applies.

Step 2: Check for Predicate Devices

If a substantially similar IVD is already licensed in India, you can follow the predicate pathway through Form MD 14. If no predicate exists, a new IVD pathway applies, requiring clinical performance evaluation permission under the applicable CDSCO process before the main license application.

Step 3: Prepare the Technical Dossier

For the MD 14 application, prepare the device description and classification, manufacturing site details, ISO 13485 certificate, CE or equivalent regulatory approvals, Free Sale Certificate from the country of origin, Performance Evaluation Report covering the required lots from an appropriate NABL-accredited laboratory, and complete stability data meeting CDSCO's IVD-specific requirements.

Step 4: Appoint an Authorized Indian Agent

An approved agent holding a manufacturing or wholesale license for sale and distribution issued pursuant to MDR 2017 may, on behalf of the distributor, apply to the authority for an import license for IVD in Form MD 14.

Step 5: Submit via SUGAM Portal

The complete application package is submitted online through CDSCO's SUGAM portal, along with the applicable fee as per the Second Schedule of MDR 2017.

Step 6: Respond to CDSCO Queries

CDSCO may request clarification or additional documentation during the review. When this happens, respond promptly to all queries within the applicable timeline. Slow or incomplete responses can extend the overall approval process.

Step 7: License Grant and Download

Once CDSCO is satisfied with the application and supporting documents, it issues the MD 15 license, which can be downloaded from the SUGAM portal.

How Missing Stability Data Delayed a Diagnostic Company's Entry

Consider a situation common across IVD importers entering India. A European diagnostics company had successfully registered its testing kits in the EU, received CE-IVD marking, and had comprehensive performance data. Its Indian partner, an experienced medical device importer, assumed the standard device documentation package would be sufficient and filed accordingly. CDSCO came back with a detailed query because the stability data submitted reflected Zone II European conditions and didn't include open-vial stability under India's Zone IVb climate. The three-lot PER data had also been generated at the manufacturer's own laboratory rather than at a NABL-accredited facility, creating an additional compliance gap. The importer had to go back to the manufacturer for new stability studies under the correct climatic conditions, source a suitable NABL-accredited laboratory, and regenerate the required PER data with the correct scope. What should have been an eight-month registration process stretched to nearly eighteen months, resulting in ten months of lost market opportunity. The example highlights why strong EU documentation does not automatically mean that an IVD application is ready for CDSCO approval in India.

Why Expert IVD Regulatory Support Makes Commercial Sense

1. Correct Pathway Identification From Day One

Predicate versus new IVD pathways can have significantly different regulatory requirements and timelines. Expert guidance can help identify the appropriate pathway before the application is submitted, reducing the risk of avoidable delays.

2. India-Specific Stability and PER Preparation

Standard EU or US documentation may not directly address every requirement applicable to an Indian IVD application. A regulatory consultant can review the existing technical dossier, identify gaps, and help prepare the required stability and performance documentation before submission.

3. NABL Lab Coordination

Knowing which NABL-accredited laboratories have the appropriate scope to test a specific IVD product category can save considerable time and help ensure that submitted performance data is supported by suitable laboratory documentation.

4. Faster Query Response

CDSCO may raise technical or documentation queries during the review process. Having a consultant familiar with the technical dossier can make it easier to prepare accurate and complete responses within the applicable timeline instead of assembling information under deadline pressure.

Final Thoughts

The CDSCO medical device import license MD 15 process for IVDs isn't simply a harder version of standard device registration; it is a regulatory pathway where performance evaluation, stability, classification, and clinical considerations can play a particularly important role. The additional technical requirements reflect the fact that IVD products can directly influence diagnosis and treatment decisions. For this reason, foreign manufacturers and Indian importers should not assume that documentation prepared for European or US markets will automatically satisfy every CDSCO requirement.

Get Expert Assistance for MD 15 IVD Import License

Planning to import IVD kits, diagnostic reagents, blood testing products, or other in-vitro diagnostic devices in India? Avoid delays caused by incorrect classification, incomplete Performance Evaluation Reports, stability data gaps, or CDSCO queries. PSR Compliance can assist with IVD classification, MD 14 application preparation, MD 15 import licensing, technical documentation, NABL laboratory coordination, and CDSCO query responses.

Call us on: (+91) 8796104190
Write to us: support@psrcompliance.com

Frequently Asked Questions

What is an MD 15 License for IVD products?

An MD 15 License is the CDSCO import license issued for importing medical devices, including applicable in-vitro diagnostic devices (IVDs), into India under the Medical Devices Rules, 2017.

Is MD 15 mandatory for importing IVD kits into India?

Yes, an applicable CDSCO import license is generally required before an IVD can be commercially imported into India. The exact regulatory pathway depends on the IVD's classification, product type, and applicable exemptions or requirements.

What is the difference between IVD and standard medical device registration?

IVDs are specifically designed to examine specimens such as blood, urine, or tissue and can directly influence diagnosis and treatment. Therefore, CDSCO may require additional performance evaluation, stability, and clinical performance information compared with conventional medical devices.

What is the Performance Evaluation Report (PER) for IVDs?

The Performance Evaluation Report (PER) provides technical evidence demonstrating the performance of an IVD, including parameters such as sensitivity, specificity, reproducibility, and repeatability, as applicable to the product.

Is NABL testing required for IVD registration?

Depending on the applicable CDSCO requirements and the nature of the IVD application, performance evaluation data may need to be generated or supported by an appropriately NABL-accredited laboratory with a relevant scope.

What stability data is required for IVD kits in India?

IVD applications may require stability evidence covering aspects such as real-time stability, accelerated stability, in-use or open-vial stability, shipping conditions, and other product-specific stability information.

What are the risk classes for IVDs in India?

Under the Medical Devices Rules, 2017, IVDs are classified into Class A, Class B, Class C, and Class D based on their associated risk. The classification affects the applicable regulatory requirements.

Does every IVD need clinical performance evaluation?

Not necessarily. The requirements depend on the IVD's classification, intended purpose, regulatory status, and whether an applicable predicate or comparable device exists in India. New or higher-risk products may face additional clinical performance requirements.

Who can apply for an MD 15 License?

The application is submitted through an Authorized Indian Agent who meets the applicable requirements under the Medical Devices Rules, 2017. Foreign manufacturers generally need an Indian authorized agent for the Indian regulatory process.

How long does it take to obtain an MD 15 License for an IVD?

The timeline depends on the IVD classification, availability and quality of technical documentation, predicate status, performance and stability data, CDSCO queries, and other regulatory factors. Applications with documentation gaps can take significantly longer.